Medical Technology Company HappiCare Raises Millions of Yuan in Seed Round

According to PEdaily.cn, HappiCare has recently a multi-million yuan seed round of financing, with participation from a number of medical institutions and angel investors. Proceeds from this financing will be used for further development and research, and the marketing of medical products for women.

HappiCare is the first medical technology company in China to use fingertip blood to detect anti-mullerian hormone(AMH) and genes associated with premature ovarian failure, and then evaluate the fertility of female. The fertility test kit developed by HappiCare is the first kind of product for women that can be used at home. It tests for AMH, sex hormones and genes associated with premature ovarian failure. All you need is a smartphone and the kit of HappiCare to get your fertility test at home.

The fertility test kit has been certified by the National Medical Products Administration (NMPA). Women can sample themselves at home by following the directions or operating video. 

HappiCare has also developed a computer vision algorithm that allows users to check, book deliveries and check reports by opening the HappiCare app on their phones. After samples being sent back, professional institutions will do related testing and medical experts will interpret test results by artificial intelligence technology and big data analytics. a straightforward female fertility testing report and personalized health tips quick can be created quickly after 7 days. When the samples are received, HappiCare recognizes them by bar code, to ensure the security of user data, samples and data in the whole detection process.

Currently, HappiCare has launched a variety of products in addition to the female fertility test kit, specifically for risk assessment of premature ovarian failure, ovarian age evaluation, the predication of menopause age. In the future, HappiCare will continue on research and development, and bring more high-quality health detection and personalized health care services to female consumers.